Staley Capital Advisers Inc. Lowers Position in Corteva, Inc. $CTVA

Staley Capital Advisers Inc. lessened its holdings in Corteva, Inc. (NYSE:CTVA) by 1.3% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 536,078 shares of the company’s stock after selling 7,070 shares during the period. Corteva comprises 1.5% of Staley Capital Advisers Inc.’s holdings, making the stock its 21st biggest position. Staley Capital Advisers Inc.’s holdings in Corteva were worth $36,255,000 as of its most recent SEC filing.

Other large investors also recently bought and sold shares of the company. Norges Bank bought a new stake in Corteva during the 2nd quarter valued at $434,220,000. Pacer Advisors Inc. grew its stake in Corteva by 4,007.1% in the third quarter. Pacer Advisors Inc. now owns 2,442,177 shares of the company’s stock valued at $165,164,000 after purchasing an additional 2,382,715 shares during the last quarter. Marshall Wace LLP raised its holdings in Corteva by 1,365.9% in the second quarter. Marshall Wace LLP now owns 1,809,764 shares of the company’s stock worth $134,882,000 after purchasing an additional 1,686,309 shares in the last quarter. National Pension Service lifted its position in shares of Corteva by 148.4% during the second quarter. National Pension Service now owns 2,454,601 shares of the company’s stock valued at $182,941,000 after buying an additional 1,466,268 shares during the last quarter. Finally, Qube Research & Technologies Ltd boosted its holdings in shares of Corteva by 566.0% in the 2nd quarter. Qube Research & Technologies Ltd now owns 1,247,120 shares of the company’s stock valued at $92,948,000 after buying an additional 1,059,872 shares in the last quarter. Institutional investors own 81.54% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts recently commented on CTVA shares. JPMorgan Chase & Co. cut shares of Corteva from an “overweight” rating to a “neutral” rating and increased their target price for the company from $75.00 to $77.00 in a research report on Thursday, February 5th. Wells Fargo & Company upped their price target on Corteva from $77.00 to $85.00 and gave the stock an “overweight” rating in a research report on Thursday, February 5th. Weiss Ratings reissued a “hold (c-)” rating on shares of Corteva in a research report on Monday, December 29th. Citigroup upped their target price on Corteva from $74.00 to $80.00 and gave the company a “neutral” rating in a research report on Thursday, February 5th. Finally, The Goldman Sachs Group reissued a “buy” rating and issued a $88.00 price target on shares of Corteva in a report on Thursday, February 5th. One investment analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and eight have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $82.30.

Corteva Price Performance

NYSE CTVA opened at $80.01 on Monday. The company has a market cap of $53.81 billion, a price-to-earnings ratio of 50.64, a PEG ratio of 2.74 and a beta of 0.72. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.43 and a quick ratio of 0.96. The stock’s fifty day moving average price is $71.91 and its 200 day moving average price is $68.79. Corteva, Inc. has a 1 year low of $53.40 and a 1 year high of $80.23.

Corteva (NYSE:CTVA) last posted its quarterly earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share for the quarter, meeting the consensus estimate of $0.22. The business had revenue of $3.91 billion for the quarter, compared to the consensus estimate of $4.23 billion. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The company’s quarterly revenue was down 1.7% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.32 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, equities research analysts forecast that Corteva, Inc. will post 2.96 earnings per share for the current year.

Corteva Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 16th. Shareholders of record on Monday, March 2nd will be given a dividend of $0.18 per share. The ex-dividend date of this dividend is Monday, March 2nd. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. Corteva’s dividend payout ratio (DPR) is currently 45.57%.

Insider Buying and Selling

In other news, insider Brian Titus sold 8,311 shares of the company’s stock in a transaction on Friday, February 20th. The shares were sold at an average price of $76.55, for a total value of $636,207.05. Following the sale, the insider directly owned 8,090 shares of the company’s stock, valued at $619,289.50. This represents a 50.67% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.15% of the company’s stock.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.